FindTrial
Sign In

Effect of exosomes from carcinoma-associated mesenchymal stem cells on ferroptosis in pancreatic cancer cells and its mechanism

Effect of exosomes from carcinoma-associated mesenchymal stem cells on ferroptosis in pancreatic cancer cells and its mechanism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050092
Enrollment
Unknown
Registered
2021-08-16
Start date
2021-09-13
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

normal pancreatic stromal group:Cell ferroptosis was induced by sorafenib
tumor stroma group:Cell ferroptosis was induced by sorafenib

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients requiring pancreatic cancer surgery.

Exclusion criteria

Exclusion criteria: Patients with serious liver, kidney, cardiovascular and cerebrovascular diseases.

Design outcomes

Primary

MeasureTime frame
Susceptibility to ferroptosis;—

Countries

China

Contacts

Public ContactShi Baomin

Shanghai Tongji Hospital

baominsph@163.com+86 18019178695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026